Seraxis is bringing transformative therapies to the millions of people worldwide struggling with the management of insulin-requiring diabetes and the associated life-threatening complications. Seraxis’ lead program, SR-02, is a novel islet replacement therapy for patients of insulin-requiring diabetes with concurrent immunosuppression therapy. This therapy is the foundation of Seraxis follow-on therapies for patients without immune suppression. Frazier Life Sciences, Polaris Partners, Eli Lilly and Company, the T1D Fund and others are investors in Seraxis.
Looking for a particular Seraxis employee's phone or email?
Seraxis Questions
The Seraxis annual revenue was $6 million in 2026.
William Rust is the Founder and CEO of Seraxis.
11 people are employed at Seraxis.
Seraxis is based in Germantown, Maryland.
The NAICS codes for Seraxis are [5417, 54171, 541714, 541, 54].
The SIC codes for Seraxis are [873, 87].
Top Seraxis Employees
-
William Rust
Founder and CEO at Seraxis
Germantown, MD, US55+ -
Pankaj Dalal
Sr Director-CMC and Process Development at Seraxis
Germantown, MD, US23 -
Karen Williams
Quality Assurance Manager at Seraxis
United States15+ -
Sam Trible
Laboratory Operations Manager at Seraxis
Washington, DC, US2 -
Octavia W.
Quality Control Scientist at Seraxis
Rockville, MD, US -
Sheryl Southard
Director of Cell Culture at Seraxis
Frederick, MD, US23 -
Laurie Rodman
Operations Compliance Manager at Seraxis
Rockville, MD, US2 -
Pankaj Dalal
Sr Director-CMC and Process Development at Seraxis
Germantown, MD, US -
Justin Bloom
Cell Culture Scientist at Seraxis
Washington, DC, US22
Related Companies
